The 2015 Controlling Cancer Summit took place on the 12th -14th May this year, in London. Current research and thinking regarding cancer screening, prevention and treatment were discussed. Presenters included Clinicians, Academics and members of the Pharmaceutical Industry.
Congratulations to our prize winners
Julie Madden,(University of Michigan, USA) and and Roshaine Gunawardana
-
- Co-Chairs, Dr Ann White (Southampton University Hospital and Dr Sophia Karagiannis (King’s College London School of Medicine, UK) UK) with feedback prize winner Roshaine Gunawardana (middle)
-
- Poster prize winner Dr Julie Madden and Dr Richard Gray (Chair). Poster Title: CYTOKINE-RICH MACROPHAGE CONDITIONED MEDIA INCREASES THE EXRESSION OF RhoC GTPase, A METASTASIS-ASSOCIATED ONCOGENE, AND THE MIGRATION OF INFLAMMATORY BREAST CANCER
The next Controlling Cancer Summit will be
17th – 19th May 2016 in London, UK
www.lifescienceevents.com/Cancer2016
10-plex 1st line chemotherapy AFP ALK-related malignancies AllergoOncology Androgen Receptor Anemia anti-angiogenic anti-cancer stem cell Antiandrogens antigen receptor Apoptosis apoptosis; kinase; leukemia; Mcl-1 astrocytoma Awareness BCR-ABL beta-catenin Beta-Tubulin isotypes bevacizumab biomarker biomarker discovery biotherapeutics body image BRAF BRCA1 BRCA2 breast breast cancer Bronchoscopy CA-125 Cancer cancer cure cancer screening registry Cancer stem cells Cancer therapeutics cancer therapy cancerawareness carcinogen Catration-Resistant Prostate Cancer CD44 CEA cell-mediated immunotherapy cervical cancer screening chemoprevention Chemorx chemotherapy Chimeric chromatin remodelling Chronic Myeloid Leukemia colorectal cancer communication Comprehensive consecutive contraception CRC CT scanning Cytopathology diagnosis drug resistance drugresistance e-health early detection Early diagnosis EGFR Elderly endobronchial epidemiology epigenetic Epigenetic markers of progression and treatment response in breast cancer Epigenetics ErbB family ErbB receptors exome exposure fertility FKBPL fluorophores FOLFIRI Gastrointestinal stromal tumor genetics Geriatric Assessment glioblastoma head and neck HER-2 IgE IgG immunochemical test Immunotherapy inhibitors Intraoperative Radiation intraoperative radiotherapy Intravenous Iron KIT leukemia linac Liver Cancer lung adenocarcinoma lung cancer mAb effector functions Macrophages mammography mammography early detection of breast cancer MCAD campaign Melanoma metastatic Microtubule minimal residual disease molecular targeted therapies Monocytes/macrophages Mouth Head and Neck Cancer MRM3 murine models Non-small-cell lung carcinoma NSCLC Nucleosomes Oncogenes oncology oncology conference optical diagnosis Ovarian Cancer over-diagnosis overdiagnosi Pancreatic Cancer Pap smear participation rate and screening peptide therapeutic personalised medicine polymorphism pre-malignancies PRM prostate cancer Prostate Specific Antigen proteomics PSA Psychosocial Support quality control Rad51 Radiation Therapy radioisotopes Reprodutive health Rhabdoid coloretal tumors risk risk assesment risk stratification s paediatric lymphoma S100 Sarcoma screen screening second line signal transduction sequencing singl test Skyline Solid tumours SRM/MRM Staging targeted screening Targeting Chemotherapy TAT therapeutic Test TKI TMT transciption Trastuzumab treatment two tyrosine kinase Ultrasound V600E Vitamin D whole Wnt signalling XRCC1 young adults
